Digital Utilities Ventures (OTC: DUTV) is evolving into Easy Environmental Solutions, Inc., to better reflect its focus on environmental sustainability....
Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025Annamycin is potentially a highly versatile drug capable...
Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025Annamycin is potentially a highly versatile drug capable...
BRENTWOOD, Tenn., April 29, 2025 (GLOBE NEWSWIRE) -- Voom Medical Devices, Inc. (“Voom” or “the Company”), a leader in minimally...
BRENTWOOD, Tenn., April 29, 2025 (GLOBE NEWSWIRE) -- Voom Medical Devices, Inc. (“Voom” or “the Company”), a leader in minimally...
SOUTH SAN FRANCISCO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company...
SOUTH SAN FRANCISCO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company...
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced...
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced...
TAIPEI, Taiwan, April 29, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through...
TAIPEI, Taiwan, April 29, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through...
Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in...
Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in...
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare...
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare...
Collaboration aims to use FYR’s AI-enabled EV-Omics (EVO) platform to produce dynamic, real-time insights into Parkinson’s diseaseMISSOULA, Mont., April 29,...
Collaboration aims to use FYR’s AI-enabled EV-Omics (EVO) platform to produce dynamic, real-time insights into Parkinson’s diseaseMISSOULA, Mont., April 29,...
BERKELEY HEIGHTS, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
BERKELEY HEIGHTS, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Study showed engineered stem cell-derived therapy recruits key immune cells and slows tumor growth, supporting continued development of Ernexa’s advanced...